Etanercept Treatment for Children and Adolescents with Plaque Psoriasis

Abstract

Etanercept significantly reduced disease severity in children and adolescents with moderate-to-severe plaque psoriasis. (ClinicalTrials.gov number, NCT00078819 [ClinicalTrials.gov].).